The average selling price for ENDEAVOR SPRINT in Japan dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the ENDEAVOR SPRINT device in Japan can be viewed in GlobalData’s micro pricing report. Buy the report here.
The ENDEAVOR SPRINT is sold by Medtronic Plc in the Coronary Stents – DES market. Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Medtronic Plc’ Coronary Stents – DES device pricing in Japan, buy the report here.